Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Journal of the European Academy of Dermatology and Venereology : JEADV|February 14, 2012
Clinical and dermoscopic features of small Reed nevus (<6 mm)V de Giorgi, I Savarese, S Rossari, et al.
The British Journal of Dermatology|September 28, 2012
Oestrogen receptor beta and melanoma: a comparative studyV de Giorgi, A Gori, S Gandini, et al.
Human Pathology|May 2, 2001
Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinomaT Susini, D Massi, M Paglierani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Expression of the retinoblastoma-related gene Rb2/p130 correlates with clinical outcome in endometrial cancerT Susini, F Baldi, C M Howard, et al.
The British Journal of Dermatology|October 18, 2018
The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based studyV De Giorgi, L Salvati, A Barchielli, et al.
Journal of Clinical Pathology|January 31, 2006
Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control studyD Massi, S Puig, A Franchi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 10, 2014
CDKN2A mutations could influence the dermoscopic pattern of presentation of multiple primary melanoma: a clinical dermoscopic genetic studyV De Giorgi, I Savarese, A D'Errico, et al.
Le Mali Medical|July 28, 2018
[Clinical and etiological aspects of focal epilepsy in children at Yaoundé Gynaeco-obstetric Hospital (Cameroon)]S Nguefack, D Massi Gams, B Moifo, et al.
The Journal of Pathology|June 29, 2007
Analysis of protease-activated receptor-1 and -2 in human scar formationS Materazzi, S Pellerito, C Di Serio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 2015
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600D Massi, D Brusa, B Merelli, et al.
Pageof 9